On our screens:Stocks with no debt
What is the market doing?
What the tape says about CAI
Caris Life Sciences, Inc. is −31% over the past year while the S&P 500 is +20%: 51 points behind the market. Through the fall, its own insiders bought $501K more stock than they sold.
−31%
1-year return · S&P 500 +20%
- vs 200-day average
- +15%
vs 200-day average · a clear uptrend
- RSI (14)
- 63
RSI (14) · neutral
- Below its 52-week high
- 37%
Below its 52-week high
Details›
- Last close2026-09-08
- $24.81
- 1 monthS&P 500 −0.30%
- +24%
- 1 yearS&P 500 +20%
- −31%
- vs 50-day average$20.09
- +24%
- 52-week high
- $39.30
- 52-week low
- $14.55
- Annualised volatility
- 66%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- $501K
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.